m+Medelevator.RU
← Поиск публикаций
Journal of gastrointestinal cancer · 2026

Long-Term Bowel Function After Low Anterior Resection with Delayed or Immediate Colo-anal Anastomosis for Rectal Cancer: the ACAQOL Study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Delattre François, Tidadini Fatah, Fournier Joey, Devant Emmanuel, Sage Pierre-Yves, Foote Alison, Faucheron Jean-Luc, Trilling Bertrand

Аннотация

INTRODUCTION: We conducted a retrospective study of all consecutive patients operated for rectal cancer with LAR and coloanal anastomosis in our tertiary center to compare the occurrence of LAR syndrome (LARS) more than 1 year after surgery between patients treated with DCAA and those with ICAA. Secondary objectives were to compare post-operative complications at 90 days. METHODS: From 2010 to 2022, 139 patients underwent LAR (ICAA, n = 45; DCAA, n = 25) with coloanal anastomosis for rectal cancer in our department. Long-term bowel function after LAR and post-operative outcomes were compared. RESULTS: After a median follow up of 48 months, the mean LARS score in the population (36 patients) was 32 (26; 37). The mean LARS score was significantly lower in the DCAA group (29 vs. 38; p < 0.001). A statistically significant association was found between the ICAA group and the LARS score, both in univariate and multivariate analysis adjusted on sex, age, BMI and ASA score; respectively (OR Beta = 9.9 [4.1–16]; p = 0.001) and (OR Beta = 10 9.5 [4.3–16]; p = 0.0032). The complication rate 90 days following surgery was 47%. D90 Severe complications were similar between two groups (p = 0.4). CONCLUSION: Our study showed that patients who underwent LAR with DCAA for rectal cancer had a better bowel outcome with a lower LARS score and similar morbidity and mortality rates at more than one year to patients who underwent LAR with ICAA. Along with the recent literature, we consider that DCAA could be an alternative to ICAA, at least in patients who refuse a stoma, whatever the reason.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты